Jounce Therapeutics, Inc. Gains 55.58%
Tue, Sep 01, 2020 at 05:30 PM
Jounce Therapeutics, Inc. (JNCE:NASDAQ) shot up at $7.53, a gain of 55.6%. The stock appeared on our News Catalysts scanner on Tue 01 Sep 20 at 08:40 AM in the 'AGREEMENT' category. From Mon 17 Aug 20, the stock recorded 50.00% Up Days and 45.45% Green Days
The share price of the company has been moving sideways in recent weeks.
About Jounce Therapeutics, Inc. (JNCE:NASDAQ)
Jounce Therapeutics Inc is a clinical stage immunotherapy company. It is engaged in transforming the treatment pf cancer by developing therapies that enable the immune system to attack tumors and provide long-lasting benefits to patients.
Top 10 Gainers:
- Jounce Therapeutics, Inc. (JNCE:NASDAQ), 55.58%
- Gogo Inc. (GOGO:NASDAQ), 43.39%
- Zoom Video Communications, Inc. (ZM:NASDAQ), 40.78%
- J.Jill, Inc. (JILL:NYSE), 40.44%
- Liberty Oilfield Services Inc. (LBRT:NYSE), 35.66%
- Evogene Ltd. (EVGN:NASDAQ), 32.37%
- NNOX (NNOX:NASDAQ), 29.72%
- TRACON Pharmaceuticals, Inc. (TCON:NASDAQ), 27.51%
- Uxin Limited (UXIN:NASDAQ), 25.74%
- Tortoise Acquisition Corp. (SHLL:NYSE), 24.16%